Intra-Cellular Therapies Inc (NAS:ITCI)
$ 83.4 -0.48 (-0.57%) Market Cap: 8.84 Bil Enterprise Value: 7.90 Bil PE Ratio: 0 PB Ratio: 7.72 GF Score: 61/100

Q1 2024 Intra-Cellular Therapies Inc Earnings Call Transcript

May 07, 2024 / 12:30PM GMT
Release Date Price: $71.21 (+0.28%)
Operator

Good morning, ladies and gentlemen, and welcome to Intra-Cellular Therapies first-quarter 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I would like now to turn the conference over to your speaker today, Dr. Juan Sanchez, Vice President, Corporate Communications and Investor Relations. Please go ahead.

Juan Sanchez
Intra-Cellular Therapies Inc - Vice President - Corporate Communications

Good morning, and thank you all for joining us on our first quarter 2024 earnings call. Joining me today on the call are Dr. Sharon Mates, Chairman and Chief Executive Officer; Mark Neumann, Chief Commercial Officer; Dr. Suresh Durgam, Chief Medical Officer; and Larry Hineline, Chief Financial Officer. The slides to help guide today's call are available on the Investor Events section of our corporate website.

I'm on slide number 2. During today's call, we will be making certain forward-looking statements. These forward-looking statements are based on current information, assumptions, and expectations

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot